Systemic diseases with panuveitis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:280933
Who is this for?
Show terms as
2Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Systemic diseases with panuveitis (Orphanet code 280933) is a clinical grouping of rare systemic conditions in which panuveitis — inflammation affecting all layers of the uveal tract (iris, ciliary body, and choroid) — occurs as a prominent ocular manifestation of an underlying systemic disease. This category encompasses a heterogeneous set of disorders where widespread inflammatory or autoimmune processes affect multiple organ systems, including the eyes, joints, skin, lungs, nervous system, and vascular system. Panuveitis in these contexts is not an isolated ocular finding but rather a sign of systemic immune dysregulation or inflammatory disease. Conditions that may present with systemic disease and panuveitis include Behçet disease, sarcoidosis, Vogt-Koyanagi-Harada disease, and certain systemic vasculitides, among others. Key symptoms depend on the specific underlying systemic condition but commonly include blurred vision, eye pain, photophobia, floaters, and redness of the eyes due to the panuveitis itself. Systemic features may include fever, skin lesions, oral or genital ulcers, joint pain, lymphadenopathy, neurological symptoms, or pulmonary involvement. If left untreated, panuveitis can lead to serious ocular complications such as cataracts, glaucoma, macular edema, retinal detachment, and permanent vision loss. Treatment typically involves addressing both the ocular inflammation and the underlying systemic disease. Corticosteroids (topical, periocular, intravitreal, or systemic) are often used as first-line therapy for acute inflammation. Steroid-sparing immunosuppressive agents such as methotrexate, azathioprine, mycophenolate mofetil, cyclosporine, or biologic therapies (e.g., anti-TNF agents like adalimumab or infliximab) may be required for chronic or refractory cases. Management is typically multidisciplinary, involving ophthalmologists, rheumatologists, and other specialists depending on the organs affected.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Systemic diseases with panuveitis.

View clinical trials →

No actively recruiting trials found for Systemic diseases with panuveitis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Systemic diseases with panuveitis community →

Specialists

2 foundView all specialists →
PM
Peter A Merkel, MD, MPH
Tampa, Florida
Specialist

Rare Disease Specialist

PI on 7 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Systemic diseases with panuveitis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Systemic diseases with panuveitisForum →

No community posts yet. Be the first to share your experience with Systemic diseases with panuveitis.

Start the conversation →

Latest news about Systemic diseases with panuveitis

No recent news articles for Systemic diseases with panuveitis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Systemic diseases with panuveitis

What is Systemic diseases with panuveitis?

Systemic diseases with panuveitis (Orphanet code 280933) is a clinical grouping of rare systemic conditions in which panuveitis — inflammation affecting all layers of the uveal tract (iris, ciliary body, and choroid) — occurs as a prominent ocular manifestation of an underlying systemic disease. This category encompasses a heterogeneous set of disorders where widespread inflammatory or autoimmune processes affect multiple organ systems, including the eyes, joints, skin, lungs, nervous system, and vascular system. Panuveitis in these contexts is not an isolated ocular finding but rather a sign

Which specialists treat Systemic diseases with panuveitis?

2 specialists and care centers treating Systemic diseases with panuveitis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.